---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-199331"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:33:53.859319+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# INOVIO enters $60M at-the-market equity distribution agreement with Oppenheimer

## Summary
- Sales agreement enables INOVIO to sell up to $60M of common stock via Oppenheimer as agent.
- Commission of up to 3% of gross proceeds; INOVIO may suspend or terminate offering at any time.
- Shares sold under existing S-3 registration statement; proceeds for general corporate purposes.
- No obligation to sell any shares; sales are at INOVIO's sole discretion and subject to market conditions.

## SEC filing metadata
- accession: 0001193125-24-199331
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312524199331/0001193125-24-199331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312524199331/d761691d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-199331
- JSON: https://secwatch.observer/filing/0001193125-24-199331.json
- Plain text: https://secwatch.observer/filing/0001193125-24-199331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.